✦ LIBER ✦

Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease

✍ Scribed by Y. Beraún; A. Nieto; M.D. Collado; A. González; J. Martín

Book ID: 110891870
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 162 KB
Volume: 52
Category: Article
ISSN: 0001-2815
DOI: 10.1111/j.1399-0039.1998.tb03028.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-509: The Tumor Necrosis Factor (TNF) a

P-509: The Tumor Necrosis Factor (TNF) alpha -308 and -863 polymorphisms are not associated with male infertility

✍ E. Bentz; D. Denschlag; I. Berner; D. Pietrowski; C. Keck; C. Tempfer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Polymorphisms of tumor necrosis factor r

Polymorphisms of tumor necrosis factor receptor 2 are not associated with insulin-dependent diabetes mellitus or Graves' disease

✍ H. Rau; H. Donner; K. H. Usadel; K. Badenhoop 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Polymorphisms in tumour necrosis factor

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation

✍ Marsh, H P; Haldar, N A; Bunce, M; Marshall, S E; le Monier, K; Winsey, S L; Chr 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB

Tumor necrosis factor-α and interleukin-

Tumor necrosis factor-α and interleukin-6 promoter gene polymorphisms are not associated with an increased risk of endometriosis

✍ Mi Kyung Lee; Ae Ja Park; Dong Ho Kim 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Tumor necrosis factor gene polymorphisms

Tumor necrosis factor gene polymorphisms are associated with coronary artery vasculopathy in heart transplant recipients

✍ L Ternstrom; A Ricksten; H Schersten; A Jeppsson; F Nilsson 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Liver diseases associated with anti-tumo

Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease

✍ Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha